Optiverder

Oomen's wealth derives from two primary sources. He served as CEO of DSW Zorgverzekeraar, a major Dutch health insurer, for over three decades. He also co-founded Optiver, one of the world's largest proprietary trading and market-making firms. The equity from Optiver's decades of global operations almost certainly forms the core of the capital deployed through Optiverder.

Optiverder and Optiver are distinct entities. Chris Oomen co-founded Optiver alongside Johann Kaemingk and Ruud Vlek. Optiverder is Oomen's personal investment vehicle and holds an equity stake in Optiver via an Amsterdam-based entity. It does not function as a corporate venturing arm for Optiver.

Yes. Oomen is associated with Anders Invest as an investor and advisor, indicating a preference for co-investment structures. Optiverder's approach to early-stage investing likely involves syndication with this network, rather than solely proprietary, isolated deal-making.

Specific portfolio holdings are not publicly disclosed. Known elements include a retained equity stake in Optiver itself and a focus on early-stage start-up ventures. The full scope of direct investments remains private, consistent with its single-principal structure.

Chris Oomen maintains separate philanthropic structures including the Daan Teeuwes Center and the Pharmaceutical Accountability Foundation. These entities operate independently from Optiverder's investment activities, reflecting a clear separation between Oomen's venture investing and his policy-oriented foundation work in healthcare.